On October 27, 2026, Welltower Inc. registered possible issuance of up to 166,666 shares under its Fellowship Grant, 334,938 shares for HCN Canadian Investment (Silver Quebec) LP unit exchanges, and 1,146,886 shares for Welltower OP LLC unit redemptions, subject to applicable conditions.
WELL · Welltower Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Welltower Inc. reported nine-month 2026 net income of 1,630,122, FFO of 3,206,992 and NOI of 4,160,720, all in thousands. It sold 315 Outpatient Medical properties under an approximately $7.2 billion portfolio sale, leaving no secured debt in the segment.
Welltower reported third-quarter normalized FFO of $1.67 per diluted share and 15.8% same-store NOI growth. It raised 2026 normalized FFO guidance to $6.47-$6.53 per diluted share and net income guidance to $3.31-$3.37 per diluted share.
Welltower reported 38% revenue growth, 35% adjusted EBITDA growth and nearly 25% FFO per share growth, raised full-year normalized FFO guidance to $6.47 to $6.53 per diluted share, and completed or announced over $21 billion of year-to-date investment activity.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Jun 23, 2026TL;DR. Welltower reported a 25.0% YoY rise in normalized FFO per share to $1.60, with 20.5% SHO same-store NOI growth, and raised full-year normalized FFO guidance to $6.36–$6.44 per share while lowering net income guidance to $3.11–$3.19 per share. The Board also increased the quarterly dividend 15% to $0.85.
- + Normalized FFO per share rose 25.0% YoY to $1.60 in Q2
- + Total SSNOI grew 15.5% YoY, led by SHO SSNOI growth of 20.5%
- + Raised full-year normalized FFO guidance to $6.36–$6.44 per share from $6.21–$6.35
- + Quarterly dividend increased 15% to $0.85, citing confidence in cash flow durability and balance sheet strength
- + Strong SHO organic growth with 9.2% revenue growth, 330 bps occupancy growth and 5.2% RevPOR growth
- + Year-to-date closed or under contract $15.5 billion of pro rata gross investments at attractive yields
- − Lowered full-year net income attributable to common stockholders guidance to $3.11–$3.19 per share from $3.24–$3.38
- − Impairment of assets of $25.8 million in Q2
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Consolidated net operating income (NOI) | $1.47B | FY2026 Q3 | +32.6% |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income (loss) $414.82M
-$114.68M Loss (gain) on real estate dispositions and acquisitions of controlling interests, net
+$30.69M Loss (income) from unconsolidated entities
+$7.12M Income tax expense (benefit)
+$124.69M Other expenses
+$33.45M Impairment of assets
+$230K Provision for loan losses, net
+$6.82M Loss (gain) on extinguishment of debt, net
+$0K Loss (gain) on derivatives and financial instruments, net
+$67.17M General and administrative expenses
+$706.79M Depreciation and amortization
+$192.66M Interest expense
= Consolidated net operating income (NOI) $1.47B
|
|||
| Average occupancy | 87.6% | the three months ended June 30, 2026 filing | — |
| FFO non-GAAP | 1.15B | Three Months Ended June 30, 2026 filing | — |
| Fixed charge coverage ratio | 6.76 | Three Months Ended June 30, 2026 filing | — |
| Interest coverage ratio non-GAAP | 7.52 | the three months ended June 30, 2026 filing | — |
| Net debt to book capitalization ratio | 25% | Three Months Ended June 30, 2026 filing | — |
| Net debt to enterprise value ratio | 9% | Three Months Ended June 30, 2026 filing | — |
| Net debt to undepreciated book capitalization ratio | 21% | Three Months Ended June 30, 2026 filing | — |
| NICS | 445M | Three Months Ended June 30, 2026 filing | — |
| NOI non-GAAP | $1.31B | Three Months Ended June 30, 2026 filing | — |
| NOI by segment: Non-segment/Corporate non-GAAP | $81.7M | Three Months Ended June 30, 2026 filing | — |
| NOI by segment: Outpatient Medical non-GAAP | $38.03M | Three Months Ended June 30, 2026 filing | — |
| NOI by segment: Seniors Housing Operating non-GAAP | $867.23M | Three Months Ended June 30, 2026 filing | — |
| NOI by segment: Triple-net non-GAAP | $407.5M | Three Months Ended June 30, 2026 filing | — |
| Same store properties (QTD Pool) non-GAAP | 499 | Three Months Ended June 30, 2026 filing | — |
| Same store properties (QTD Pool) - Outpatient Medical non-GAAP | 89 | Three Months Ended June 30, 2026 filing | — |
| Seniors Housing Operating Property mix | 66% | Three Months Ended June 30, 2026 filing | — |
| SSNOI non-GAAP | $805.82M | the three months ended June 30, 2026 filing | — |
| SSNOI at Welltower Share - Outpatient Medical non-GAAP | $26.9M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationConsolidated NOI 38.03M (non-GAAP)
+4.45M NOI attributable to unconsolidated investments
-969K NOI attributable to noncontrolling interests
-11.58M NOI attributable to non-same store properties
-3.04M Non-cash NOI attributable to same store properties
= SSNOI at Welltower Share - Outpatient Medical 26.9M
|
|||
| SSNOI at Welltower Share - Seniors Housing Operating non-GAAP | $582.62M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationConsolidated NOI 867.23M (non-GAAP)
+21.13M NOI attributable to unconsolidated investments
-15.46M NOI attributable to noncontrolling interests
-288.15M NOI attributable to non-same store properties
-1.29M Non-cash NOI attributable to same store properties
-833K Currency and ownership adjustments
= SSNOI at Welltower Share - Seniors Housing Operating 582.62M
|
|||
| SSNOI at Welltower Share - Total non-GAAP | $805.82M | Three Months Ended June 30, 2026 filing | — |
| SSNOI at Welltower Share - Triple-net non-GAAP | $196.31M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationConsolidated NOI 407.5M (non-GAAP)
-1.03M NOI attributable to noncontrolling interests
-172.51M NOI attributable to non-same store properties
-37.39M Non-cash NOI attributable to same store properties
-259K Currency and ownership adjustments
= SSNOI at Welltower Share - Triple-net 196.31M
|
|||
| SSNOI property count: Outpatient Medical (consolidated) non-GAAP | 54 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Outpatient Medical (unconsolidated) non-GAAP | 73 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Seniors Housing Operating (consolidated) non-GAAP | 1,869 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Seniors Housing Operating (unconsolidated) non-GAAP | 125 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total non-GAAP | 2,950 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total (consolidated) non-GAAP | 2,752 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total (unconsolidated) non-GAAP | 198 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total Outpatient Medical non-GAAP | 127 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total Seniors Housing Operating non-GAAP | 1,994 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Total Triple-net non-GAAP | 829 | Three Months Ended June 30, 2026 filing | — |
| SSNOI property count: Triple-net (consolidated) non-GAAP | 829 | Three Months Ended June 30, 2026 filing | — |
| Triple-net Property mix | 31% | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WELL
this stock
Welltower Inc.
|
$179.48B | +31.8% | +35.6% | 106.4 | 2.4% |
|
VTR
Ventas, Inc.
|
$47.00B | +14.9% | +18.5% | 167.7 | 2.8% |
|
OHI
Omega Healthcare Investors Inc
|
$14.33B | +6.2% | +13.2% | 18.9 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$13.68B | +23.4% | +4.5% | 36.7 | 3.3% |
|
AHR
American Healthcare REIT, Inc.
|
$13.48B | +23.4% | +9.1% | 116.1 | 14.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 27, 2026
- This year
- 18
Welltower Inc. reported nine-month 2026 net income of 1,630,122, FFO of 3,206,992 and NOI of 4,160,720, all in thousands. It sold 315 Outpatient Medical properties under an approximately $7.2 billion portfolio sale, leaving no secured debt in the segment.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WELL | -1.1% | +4.8% | +14.2% | +4.3% | +31.8% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | +0.6% | +8.2% | +15.6% | +6.4% | +23.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.